UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
| |
|
|
Date of Report (Date of earliest event reported)
|
|
November 13, 2007 |
|
|
|
NATURAL HEALTH TRENDS CORP.
(Exact name of Company as specified in its charter)
| |
|
|
|
|
| Delaware
|
|
0-26272
|
|
59-2705336 |
| |
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
IRS Employer
Identification No.) |
| |
|
|
|
|
| 2050 Diplomat Drive
|
|
Dallas, TX
|
|
75234 |
| |
(Address of principal executive offices)
|
|
(Zip Code) |
| |
|
|
Company’s telephone number, including area code
|
|
(972) 241-4080 |
|
|
|
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the Company under any of the following provisions
(see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
(17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
|
|
|
| Item 3.01 |
|
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. |
On November 13, 2007, Natural Health Trends Corp. (the “Company”) received a letter from The
Nasdaq Stock Market (the “Nasdaq Letter”) stating that the Company is not in compliance with
the audit and compensation committee requirements for continued listing on The Nasdaq Stock
Market under Marketplace Rules 4350(d)(2) and 4350(c)(3), respectively. As
previously disclosed, Anthony B. Martino resigned from the Company’s Board of Directors on
October 19, 2007. Mr. Martino was the Chairman of the Audit Committee and a member of the
Compensation Committee. The Nasdaq Letter provides the Company with a cure period in order
to regain compliance until the earlier of the Company’s next annual shareholders’ meeting or
October 19, 2008, or, if the Company’s next annual shareholders’ meeting is held before April
16, 2008, then the Company must evidence compliance by April 16, 2008. The Company intends
to regain compliance within this cure period.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Company
has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
| |
|
|
|
|
| |
|
NATURAL HEALTH TRENDS CORP. |
|
|
|
|
|
Date: November 19, 2007 |
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Chris Sharng |
|
|
|
|
|
|
|
|
|
Name: Chris Sharng |
|
|
|
|
Title: President |
2